Related Experiment Videos
The role of health-risk appraisals in disease management
Laurel R Hudson1, James E Pope
1Department of Informatics, American Healthways, Inc., Nashville, Tennessee, USA. laurel.hudson@amhealthways.com
Abstract:
Managed care organizations and disease management vendors often find themselves in the position of responding to employers who want to administer a health-risk appraisal (HRA) without committing to implementation of a comprehensive health promotion program. The assumption appears to be that information on health risks is sufficient to motivate employees to change their health behaviors in order to reduce estimated health risks. A review of the relevant literature does not substantiate the efficacy of a stand-alone HRA for motivating behavior change. The challenge is to engage employers in informed conversations on what works in health promotion and achieve cost-effective benefits.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Hazard Ratio
For example, in a clinical trial evaluating a...
Purpose of Health Records I
Here's a breakdown of how health records serve these purposes:
Models of Health Promotion and Illness Prevention II
The agent-host-environment model states that disease results from...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...